BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kundishora AJ, Peters ST, Pinard A, Duran D, Panchagnula S, Barak T, Miyagishima DF, Dong W, Smith H, Ocken J, Dunbar A, Nelson-Williams C, Haider S, Walker RL, Li B, Zhao H, Thumkeo D, Marlier A, Duy PQ, Diab NS, Reeves BC, Robert SM, Sujijantarat N, Stratman AN, Chen YH, Zhao S, Roszko I, Lu Q, Zhang B, Mane S, Castaldi C, López-Giráldez F, Knight JR, Bamshad MJ, Nickerson DA, Geschwind DH, Chen SL, Storm PB, Diluna ML, Matouk CC, Orbach DB, Alper SL, Smith ER, Lifton RP, Gunel M, Milewicz DM, Jin SC, Kahle KT. DIAPH1 Variants in Non-East Asian Patients With Sporadic Moyamoya Disease. JAMA Neurol 2021;78:993-1003. [PMID: 34125151 DOI: 10.1001/jamaneurol.2021.1681] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen T, Wei W, Yu J, Xu S, Zhang J, Li X, Chen J. The Progression of Pathophysiology of Moyamoya Disease. Neurosurgery 2023. [PMID: 36912514 DOI: 10.1227/neu.0000000000002455] [Reference Citation Analysis]
2 Qureshi HM, Mekbib KY, Allington G, Elsamadicy AA, Duy PQ, Kundishora AJ, Jin SC, Kahle KT. Familial and syndromic forms of arachnoid cyst implicate genetic factors in disease pathogenesis. Cereb Cortex 2023;33:3012-25. [PMID: 35851401 DOI: 10.1093/cercor/bhac257] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Kundishora AJ, Allington G, McGee S, Mekbib KY, Gainullin V, Timberlake AT, Nelson-Williams C, Kiziltug E, Smith H, Ocken J, Shohfi J, Allocco A, Duy PQ, Elsamadicy AA, Dong W, Zhao S, Wang YC, Qureshi HM, DiLuna ML, Mane S, Tikhonova IR, Fu PY, Castaldi C, López-Giráldez F, Knight JR, Furey CG, Carter BS, Haider S, Moreno-De-Luca A, Alper SL, Gunel M, Millan F, Lifton RP, Torene RI, Jin SC, Kahle KT. Multiomic analyses implicate a neurodevelopmental program in the pathogenesis of cerebral arachnoid cysts. Nat Med 2023. [PMID: 36879130 DOI: 10.1038/s41591-023-02238-2] [Reference Citation Analysis]
4 Kahle KT, Duran D, Smith ER. Increasing precision in the management of pediatric neurosurgical cerebrovascular diseases with molecular genetics. J Neurosurg Pediatr 2023;31:228-37. [PMID: 36609371 DOI: 10.3171/2022.12.PEDS22332] [Reference Citation Analysis]
5 Ilinca A, Puschmann A, Putaala J, de Leeuw FE, Cole J, Kittner S, Kristoffersson U, Lindgren AG. Updated Stroke Gene Panels: Rapid evolution of knowledge on monogenic causes of stroke. Eur J Hum Genet 2023;31:239-42. [PMID: 36253534 DOI: 10.1038/s41431-022-01207-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Li S, Han Y, Zhang Q, Tang D, Li J, Weng L. Comprehensive molecular analyses of an autoimmune-related gene predictive model and immune infiltrations using machine learning methods in moyamoya disease. Front Mol Biosci 2022;9:991425. [PMID: 36605987 DOI: 10.3389/fmolb.2022.991425] [Reference Citation Analysis]
7 Hausman-Kedem M, Herring R, Torres MD, Santoro JD, Kaseka ML, Vargas C, Amico G, Bertamino M, Nagesh D, Tilley J, Schenk A, Ben-Shachar S, Musolino PL. The Genetic Landscape of Ischemic Stroke in Children - Current Knowledge and Future Perspectives. Semin Pediatr Neurol 2022;44:100999. [PMID: 36456039 DOI: 10.1016/j.spen.2022.100999] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Larson AS, Klaas JP, Johnson MP, Benson JC, Shlapak D, Lanzino G, Savastano LE, Lehman VT. Vessel wall imaging features of Moyamoya disease in a North American population: patterns of negative remodelling, contrast enhancement, wall thickening, and stenosis. BMC Med Imaging 2022;22:198. [DOI: 10.1186/s12880-022-00930-2] [Reference Citation Analysis]
9 Lehman LL, Kaseka ML, Stout J, See AP, Pabst L, Sun LR, Hassanein SA, Waak M, Vossough A, Smith ER, Dlamini N. Pediatric Moyamoya Biomarkers: Narrowing the Knowledge Gap. Semin Pediatr Neurol 2022;43:101002. [PMID: 36344019 DOI: 10.1016/j.spen.2022.101002] [Reference Citation Analysis]
10 Esmaeilzadeh H, Noeiaghdam R, Johari L, Hosseini SA, Nabavizadeh SH, Alyasin SS. Homozygous Autosomal Recessive DIAPH1 Mutation Associated with Central Nervous System Involvement and Aspergillosis: A Rare Case. Case Reports in Genetics 2022;2022:1-5. [DOI: 10.1155/2022/4142214] [Reference Citation Analysis]
11 Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H, Yoshimoto T, Miyawaki S, Clausen T, Bang OY, Steinberg GK, Tournier-lasserve E, Koizumi A. Moyamoya disease: diagnosis and interventions. The Lancet Neurology 2022. [DOI: 10.1016/s1474-4422(22)00165-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
12 He S, Ye X, Duan R, Zhao Y, Wei Y, Wang Y, Liu Z, Hao X, Chen X, Hao Q, Wang H, Zhao Y, Wang R, Tahmasbpour E. Epigenome-Wide Association Study Reveals Differential Methylation Sites and Association of Gene Expression Regulation with Ischemic Moyamoya Disease in Adults. Oxidative Medicine and Cellular Longevity 2022;2022:1-13. [DOI: 10.1155/2022/7192060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Labat-de-Hoz L, Alonso MA. Formins in Human Disease. Cells 2021;10:2554. [PMID: 34685534 DOI: 10.3390/cells10102554] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Mertens R, Graupera M, Gerhardt H, Bersano A, Tournier-Lasserve E, Mensah MA, Mundlos S, Vajkoczy P. The Genetic Basis of Moyamoya Disease. Transl Stroke Res 2021. [PMID: 34529262 DOI: 10.1007/s12975-021-00940-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]